Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...
"There are so many people there to help you and they will do all they can. If you have any symptoms or any concerns at all, please go and get tested." ...
Across the UK, pub bells will ring early for the final time this Wednesday as part of a new campaign by Greene King and Macmillan Cancer Support ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...
The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...
Study finds similar safety regardless of anticoagulant type.In a study of adults with advanced prostate cancer taking androgen-receptor pathway ...
Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.
Men receiving treatment for prostate cancer often face challenges that extend well beyond the disease itself. A new study led ...
Two Aberdeenshire farmers are urging men to seek prostate cancer checks, sharing their personal experiences through charity-backed videos to promote early ...
Suit alleges that J&J made "false claims regarding the efficacy of Nubeqa," Bayer's drug that former NFL quarterback Tony ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results